Literature DB >> 20170317

Factors associated with the control of severe asthma.

Juan Luis Rodriguez Hermosa1, Carlos Barcina Sánchez, Myriam Calle Rubio, Mercedes Muñoz Mínguez, Jose Luis Alvarez-Sala Walther.   

Abstract

INTRODUCTION: Control is a priority treatment objective in asthma, and classification based on control is recommended in the follow-up of asthmatic patients. Different factors affect this control, and there are several regional differences, both in terms of prevalence and in terms of management and degree of control.
OBJECTIVE: To evaluate the factors associated with control of severe asthma in routine clinical practice.
MATERIAL AND METHODS: This was a prospective, cross-sectional, observational study of patients with severe asthma who were receiving treatment with a fixed combination of a corticosteroid (at least 800 microg/day of budesonide or equivalent) and an inhaled beta(2)-adrenergic agonist in respiratory medicine and allergology clinics throughout Spain. The authors collected demographic and socioeconomic data, as well as clinical data on asthma. The patients also completed a self-administered validated questionnaire-the Asthma Control Questionnaire (ACQ)-about the control of their asthma.
RESULTS: The authors included 1471 patients, of whom 1224 (83%) were valid for the final analysis. Women accounted for 61%. Mean age was 51 +/- 16 years. The mean number of exacerbations during the previous year was 2.0 +/- 2.0. The global score on the ACQ was 1.8 +/- 1.1 (0 = no symptoms; 6 = maximum number of symptoms). Only 20.4% of patients were well controlled (ACQ < 0.75), and 55.7% of patients were poorly controlled (ACQ > 1.5). The multivariate analysis revealed that the variable with the greatest effect on control of asthma was the number of exacerbations during the previous year: when the number of exacerbations increased from 0 to 1 or more, the ACQ score increased by 0.56 points. Employed patients had a mean of 0.23 points less (better control) than unemployed and retired patients. Control of asthma was also significantly affected by adherence to treatment, patient knowledge of the disease, body mass index, gender, and number of visits to a physician in the previous 3 months.
CONCLUSIONS: Many patients with severe asthma have poor control of their disease. The number of exacerbations is the variable with the greatest effect on control of asthma. Knowledge of the disease and adherence to treatment are associated with better control.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20170317     DOI: 10.3109/02770900903518835

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  20 in total

Review 1.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

2.  Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.

Authors:  María Del Carmen Vennera; Antonio Valero; Estefany Uría; Carles Forné; César Picado
Journal:  Clin Drug Investig       Date:  2016-07       Impact factor: 2.859

3.  Co-morbid psychological dysfunction is associated with a higher risk of asthma exacerbations: a systematic review and meta-analysis.

Authors:  Li Zhang; Xin Zhang; Jing Zheng; Lan Wang; Hong-Ping Zhang; Lei Wang; Gang Wang
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

4.  Gender-specific asthma treatment.

Authors:  Inseon S Choi
Journal:  Allergy Asthma Immunol Res       Date:  2010-11-08       Impact factor: 5.764

5.  Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.

Authors:  Ashley Woodcock; Eric D Bateman; William W Busse; Jan Lötvall; Neil G Snowise; Richard Forth; Loretta Jacques; Brett Haumann; Eugene R Bleecker
Journal:  Respir Res       Date:  2011-10-06

6.  Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early.

Authors:  Tanja T Menckeberg; Jacqueline G Hugtenburg; Jan Willem Lammers; Jan A M Raaijmakers; Marcel L Bouvy
Journal:  Int J Clin Pharm       Date:  2012-04

7.  Communication during counseling sessions about inhaled corticosteroids at the community pharmacy.

Authors:  Jeanine A Driesenaar; Peter Agm De Smet; Rolf van Hulten; Litje Hu; Sandra van Dulmen
Journal:  Patient Prefer Adherence       Date:  2016-11-02       Impact factor: 2.711

8.  Appropriate selection for omalizumab treatment in patients with severe asthma?

Authors:  Leo Nygaard; Daniel Pilsgaard Henriksen; Hanne Madsen; Jesper Rømhild Davidsen
Journal:  Eur Clin Respir J       Date:  2017-08-07

9.  Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians.

Authors:  David Price; Brooke Harrow; Mark Small; James Pike; Victoria Higgins
Journal:  World Allergy Organ J       Date:  2015-09-10       Impact factor: 4.084

10.  Relationship between medication beliefs, self-reported and refill adherence, and symptoms in patients with asthma using inhaled corticosteroids.

Authors:  Mna Van Steenis; Ja Driesenaar; Jm Bensing; R Van Hulten; Pc Souverein; L Van Dijk; Pagm De Smet; Am Van Dulmen
Journal:  Patient Prefer Adherence       Date:  2014-01-13       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.